Overview

Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)

Status:
Not yet recruiting

Trial end date:
2027-01-01

Target enrollment:

Participant gender:

Summary

This study will examine the synaptotrophic effects of psilocybin among medically healthy, detoxified OUD subjects. Eligible OUD participants will undergo pre- and post- psilocybin administration PET scans with the [11C]-UCB-J radiotracer while inpatient.

Phase:

Phase 1

Details

Lead Sponsor:

Yale University

Collaborator:

National Institute on Drug Abuse (NIDA)

Treatments:

Psilocybin